At the Mayo Clinic, Dr. Guifang Zhao is leading a new generation of regenerative medicine therapies that combine the ...
A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...
A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...
The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...
Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency partially depends ...
Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology ...
The CRISPR “gene scissors” have become an important basis for genome-editing technologies in many fields, ranging from biology and medicine to agriculture and industry. A team from the Helmholtz ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Lead program UKK-0018 for peanut allergy has received regulatory clearance in AU and NZ to begin clinical trials in 1H 2026Expands leadership with appointment of Grace Chen-Philips, M.D., as Chief ...
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
StockStory.org on MSN
Q3 earnings outperformers: Novavax (NASDAQ:NVAX) and the rest of the therapeutics stocks
Looking back on therapeutics stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Novavax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback